苏州贝康医疗股份有限公司

Basecare Medical Co., Ltd. is the most robust, innovative, and a leading company in the NGS segment-reproductive field, it is the pioneer leader of high-throughput sequencing technology in the field of comprehensive reproductive health. Basecare remains at the forefront of the leading talent. Furthermore, it is a “Unicorn” cultivation enterprise in Suzhou. The B3 building has a production center of 1364㎡ along with a research center of 6271㎡ at the A3 building.
The one ideology we constantly uphold is “Quality First”. We followed strict specifications in developing, licensing, and certifying our products. Over the years, we have made some substantial progress. In 2015, we applied for our PGT-A kit to be classified as Class-III Medical Devices, and regulated by the Standardization Administration. In 2016, the PGT-A kit was granted special approval for innovative medical devices to enter the phase of clinical trial. In 2017, we participated in the formulation of QCS (quality control specification) for all PGT-A products. In 2018, we obtained the qualification of GMP workshop production. Finally, in Feb. 21 2020, our PGT-A kit won the CFDA approval, signifying the beginning of a new era in which China’s IVF technology is licensed and regulated under CFDA.
Our goal is to help more and more infertile spouses have their own babies. In doing so, we hope to contritute to the reproductive health and well-bing of all mankind. hence, we will indefatigably march towards our BaseCare Vision.